Name Artemether
Classes Antiinfective Agent
Antimalarial Agent
Diseases Infectious Disease
Malaria

Artemether

Artemether is an antimalarial drug used to treat acute malaria without complications. It's used in conjunction with lumefantrine to boost its effectiveness. This combination therapy works against Plasmodium spp. erythrocytic stages and can be used to treat infections caused by P. falciparum and other Plasmodium species, as well as infections acquired in chloroquine-resistant areas.

Artemether is rarely used alone, it is almost always used in combination with lumefantrine to treat malaria.

  • Artemether is administered in combination with lumefantrine. The dosage is as follows-
    • 5 to < 15 kg: 1 tablet
    • 15 to < 25 kg: 2 tablets
    • 25 to < 35 kg: 3 tablets
    • 35 kg and over: 4 tablets
  • Each tablet contains 120 mg lumefantrine and 20 mg artemether.
  • This medication should be taken with food & maybe crushed while taking.
  • Tablets should be administered over 3 days for a total of 6 doses: an initial dose, second dose after 8 hours and then twice-daily (morning and evening) for the following 2 days.

Artemether (along with lumefantrine) may cause the following side effects-

  • headache
  • anorexia
  • dizziness
  • asthenia
  • arthralgia
  • myalgia

The most common adverse reactions in children (greater than 12%) are pyrexia, cough, vomiting, anorexia, and headache.

  • Patients with known QT prolongation, hypokalemia or hypomagnesemia, and those taking other drugs that prolong the QT interval should avoid using it.
  • Due to limited safety data, antimalarials should not be given concurrently unless there are no other treatment options.
  • Following Artemether (along with lumefantrine) Tablets, QT prolonging drugs such as quinine and quinidine should be used with caution.
  • Substrates, inhibitors, or inducers of CYP3A4, including antiretroviral medications, should be used with caution with Artemether (along with lumefantrine) Tablets due to the possibility of decreased efficacy or additive QT prolongation.

Contraindication

Artemether (& lumefantrine) is contraindicated in-

  • Coadministration of strong inducers of CYP3A4 of the following drugs is contraindicated-
  • Contraindicated in patients with hypersensitive to artemether & lumefantrine.

Coadministration with St. John's wort is contraindicated.